Short answer. Until the 1960s, drug cannabis was mostly regional landraces. From the late 1960s and 1970s, North American growers imported seed from Mexico, Colombia, Thailand, India and, crucially, Afghanistan, and crossed the long-flowering narrow-leaflet types with early, resinous Afghan types to get plants that finished outdoors in temperate climates and indoors under lights. Dutch seed companies spread these hybrids worldwide from the mid-1980s. Clone trading and, later, legal markets multiplied the names [1][2]. The broad arc is Supported; nearly every specific pedigree is a claim.
The arc, with evidence labels
| Period | What happened | Evidence |
|---|---|---|
| 1960s-70s | Imported export-grade cannabis (Mexico, Colombia, Jamaica, Thailand) brings seed to North America; outdoor growing begins in earnest | Supported [1] |
| Mid-late 1970s | Afghan seed reaches California; crosses with long-flowering types prove early and productive | Supported as history [1][2]; exact dates vary between accounts [6][7] |
| Late 1970s-early 1980s | Named stabilised hybrids appear (e.g., Skunk #1, Haze family, Northern Lights family) | Lines' existence Supported; pedigrees L1 with conflicting versions [6][7] |
| 1980s | Indoor growing under HID lights rewards short, early, Afghan-heavy hybrids | Supported [1] |
| Mid-1980s | Dutch seed companies collect North American lines and sell seed internationally; Amsterdam cannabis competitions popularise names | Supported as history; company details L1 [6] |
| 1990s-2000s | Clone-only selections spread hand to hand (the Kush and "OG" families, Chemdawg-related cuts, Diesel types) | Names Supported; origins mostly L0-L1 |
| 2000s-2010s | Online seed trade and forums; feminised seed becomes common; explosion of crosses and names | Supported |
| 2010s-2020s | Legal markets; CBD-rich drug-type lines, often traced to hemp introgression [4]; autoflower hybrids; brand-driven naming | CBD from hemp introgression Supported [4] |
Conflicting claims: one worked example
Skunk #1 is a useful example of why GenetixBay records claims rather than "facts". Popular histories agree it came from a California seed operation (often named as Sacred Seeds) and reached the Netherlands in the 1980s, and that it won an early Amsterdam competition. They disagree on details [6][7]:
| Claim | Version A | Version B | Level |
|---|---|---|---|
| Pedigree | (Afghani x Colombian Gold) x Acapulco Gold | Three-way of Afghani, Colombian and Mexican without order | L1 |
| Release date | 1976 | Late 1970s / early 1980s | L1 |
| Arrival in the Netherlands | 1985 | Mid-1980s, date varies | L1 |
| First major award | 1987 | 1988 | L1being reviewed |
On a GenetixBay record, each version is a separate claim with its source and level. None reaches L3 without period documents (catalogues, dated publications), and none reaches L4 without DNA from documented reference material.
What genetics says about the big picture
- Commercial drug-type cannabis forms a gene pool distinct from hemp, with internal structure that only partly matches reported "sativa/indica" ancestry [3] (Supported).
- Widespread hybridisation over roughly the past 50 years has blurred historical distinctions [2] (Supported).
- Modern drug-type lines are a mix of many landrace sources and are highly heterozygous [5] (Supported).
- High-CBD drug-type lines carry hemp-derived genome segments around the CBDAS region [4] (Supported).
- Even the US government's research supply was genetically unlike state-market cannabis [8], a reminder that "cannabis" in older studies may not represent today's plants.
Common mistakes
- Repeating a famous pedigree as fact because it is printed on many seed shop pages. Repetition is not evidence.
- Assuming a modern seed line with a classic name is the original population.
- Treating a single breeder interview, decades later, as documentation. It is a first-hand claim (valuable, L1-L2), not a period record.
